• Home
  • Search Results

Search Results

2587 studies match your search
Coming Soon

LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Early-Stage Breast Cancer

The purpose of this study is to compare the usual treatment with hormonal therapy medications to treatment with low-dose tamoxifen. This study will help the study doctors find out if this different approach is the same as the usual approach. To decide if it is better, the study doctors will be looking to see if low-dose tamoxifen has the same chance of preventing breast cancer from returning compared to the usual hormonal therapy medications with less side effects

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Breast)
  • Women's Health
Open

Heels 2 Participation (H2P) Interviews

Are you an adult with an intellectual disability (ID/D) age 18 to 30 years? Would you and your adult care partner like to participate in a one-hour zoom interview together to answer questions that can help researchers learn about school and community experiences and technology use that helps people with ID/D transition to adulthood? Digitial gift card compensation provided to both participants.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Developmental
Visit Location
100% Remote (online, phone, text)
Coming Soon

The FoRtitude Interview Study

The goal of this research study is to interview breast cancer survivors who self-identify as Black/African American to obtain feedback and suggestions on refining the FoRtitude 2.0 eHealth intervention.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Breast)
  • Women's Health
Visit Location
100% Remote (online, phone, text)
Coming Soon

Testing BI 765179 alone and in combination with ezabenlimab in advanced cancer (solid tumors) and BI 765179 in combination with pembrolizumab in advanced head and neck cancer

This study is being done to see if the study drug, called BI 765179, in combination with another drug called pembrolizumab, can help people with advanced head and neck cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck)
Coming Soon

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

The purpose of this study is to determine if the use of Olaparib for one year is as effective in treating ovarian cancer as the current standard of care treatment and if Olaparib prevents growth and or recurrence.

Age & Gender
  • 18 years ~ 99 years
  • Female, Gender Inclusive
Study Interest
  • Cancer (Uterine (endometrial), Ovarian)
  • Women's Health
Open

S2212-CIRB: Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study (NCT TBD)

Have you been diagnosed with early stage triple negative breast cancer and not yet received treatment? If so, you may be eligible for a trial comparing the use two different regimens of chemotherapy-immunotherapy treatments prior to surgery.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Breast)
Coming Soon

A Study of YL201 in Patients With Advanced Solid Tumors

This is a study of an investigational drug called YL201 as a possible treatment for advanced solid tumors. YL201 is thought to work by interrupting DNA replication in cancer cells, via focused delivery of the cytotoxic agent to the cancer cell. YL201 has shown some anti-cancer effects against cancer cells in the laboratory and in experimental animals. The main purpose of this study is to learn how safe the study drug and how well the study drug works.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck, Lung)
Not currently enrolling

Young Adult Drinking Study

This study is assessing the usefulness of a text message based intervention to reduce excessive alcohol use among young adults ages 18-25. Participants will attend a Baseline Session over Zoom where they will complete a 25-minute survey and learn more about study procedures. Then, participants will receive daily prompts to their personal cellphone Wednesday-Sunday for 4 weeks. After the 4-week trial, participants will attend 1 focus group over Zoom to share their experiences in the study.

Age & Gender
  • 18 years ~ 25 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Substance Use (tobacco, alcohol, opioids, etc)
Visit Location
100% Remote (online, phone, text)
Coming Soon

PROGRESS: Precision Oncology using Genomic Reflexive Evaluations for Study Selection and Survival

The purpose of this research study is to look at a program that includes expert review of your tumor genetic test results. We want to see if this program can help your doctor identify better treatments or suitable clinical trials for your cancer. This is a hybrid decentralized study where some if not all assessments may be performed remotely or close to your home.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Breast, Colorectal, Lung)
Open

Mental Health Study

Is your child between the ages of 8 and 11? Was your child assigned female sex at birth? If so, you may be able to take part in a study to see how social experiences and puberty can affect the mental health of preteen girls. We want to help improve youth mental health support. Compensation provided.

Age & Gender
  • 8 years ~ 99 years
  • Female, Gender Inclusive
Study Interest
  • Behavior
  • Developmental
  • Glands and Hormones
  • and 6 more
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research